SciELO - Scientific Electronic Library Online

 
vol.72 número2Determinación de concentraciones séricas de 25(OH) D en niños con lupus eritematoso sistémico y artritis idiopática juvenilImplicaciones nutricionales de las dietas de eliminación índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Boletín médico del Hospital Infantil de México

versão impressa ISSN 1665-1146

Resumo

MORALES-RIOS, Olga et al. Do pediatricians identify adverse drug reactions even when they do not report them?. Bol. Med. Hosp. Infant. Mex. [online]. 2015, vol.72, n.2, pp.106-111. ISSN 1665-1146.  https://doi.org/10.1016/j.bmhimx.2015.04.003.

Introduction:

Spontaneous notification depends on the ability of pediatricians to identify adverse drug reactions (ADRs) along with their habit of reporting these incidents. During the years 2008 and 2009, the frequency of reports of ADRs to the Electronic Program of Pharmacovigilance (SISFAR) in the Hospital Infantil of Mexico Federico Gomez (HIMFG) was low (0.44% and 0.20%, respectively). Because of the above, the ability of pediatricians from the Emergency Department (ED) to identify ADRs using the clinical chart review was evaluated in 2010 in this study.

Methods:

A descriptive, observational, cross-sectional retrospective study was conducted in the ED from March 1 to August 31. ADRs were classified and quantified as "ADRs identified by pediatricians" when there was evidence in the clinical chart that pediatricians associated a clinical sign, symptom and laboratory value with an ADR. The numbers of notifications reported in SISFAR were quantified. Descriptive analysis was done using SPSS v.18.

Results:

Considering patients who were admitted to the ED, the frequency of ADRs was 21.8%. The frequency of ADRs identified by physicians in clinical charts was 86%. The pharmacist detected 14% of ADRs. The frequency of ADRs reported by physicians was 6.1%.

Conclusions:

Although identification of ADRs in the clinical charts by pediatricians was high, it is possible that some ADRs were undetected. Because underreporting was very high, it is necessary to take actions to improve the reporting process.

Palavras-chave : Pharmacovigilance; Adverse drug reaction; Pediatric hospitals.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )